Joydev Acharya, MD
Cardiovascular Disease (Cardiology) · Modesto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location · Stanislaus Cardiology Group · 6 clinicians in this group
Looking this up.
Hospitals listed: Doctors Medical Center · Memorial Medical Center · Oak Valley Hospital District. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Acharya’s office at (209) 521-9661 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A96042 · Current
Licensed to practise in California · since 2006 · expires 2028-02-29 · University of Texas Southwestern Medical School at Dallas.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Summit Surgery Center Modesto, IncAmbulatory Surgery Center · Modesto, CA20% owner since 2019 · accredited by AAAHCAccreditation Renewed2 inspections, 2 with deficiencies · last 2024-04-05: Requirements Met
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Doctors Medical CenterModesto, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.36 (1.02 to 1.71), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.35 (0.81 to 1.9) · 6,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.281, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.326, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.183, Oct 2024 – Sep 2025
- Memorial Medical CenterModesto, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.093, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
- Oak Valley Hospital DistrictOakdale, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Doctors Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 3 the same, 1 worse of 6 measures. Readmissions: 0 better, 5 the same, 3 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.36 (1.02 to 1.71) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.35 (0.81 to 1.9) · 6,296 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.281 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.326 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.183 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.31 to 2.23) · 1,396 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 183.31 (147.26 to 219.36) · 127 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 4.1 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.1 · 95 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 15.2 · 276 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.8 · 321 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 364 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.9 · 767 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 3,719 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 7,050 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,169 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.12 (2.19 to 6.06) · 1,622 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.6 (0 to 3.3) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.23 to 4.04) · 1,601 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 14.79 (5.73 to 23.85) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (0.75 to 9.23) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.9 · 67 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.484 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.582 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 424 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24 · 682 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 36.6 · 326 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 70.5 · 378 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 366 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 564 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 70 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.7 · 120 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.4) · 573 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.7) · 303 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,045 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 57% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 36% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Memorial Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.093 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.41 to 2.2) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.75 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.77 (144.66 to 226.88) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.1 · 194 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 513 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 640 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 4,882 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.42) · 10,183 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 10,422 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.4 (1.58 to 5.23) · 2,596 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.92 (0.45 to 3.38) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.1 (1.78 to 4.42) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.71 (5.69 to 17.72) · 885 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.28 (3.75 to 10.81) · 829 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 563 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.72) · 9,080 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 283 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.389 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.485 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.507 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 255 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 849 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 19.2 · 201 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.4 · 584 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.6 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 895 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.3 to 6.9) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 273 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 341 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.2 to 16.1) · 2,334 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 717 cases | No different | Jan 2024 – Dec 2024 |
What patients said (655 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Oak Valley Hospital District
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 2 the same, 2 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.47 to 1.48) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 19.1 · 41 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 122 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 387 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 391 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.58 (0 to 1.88) · 243 cases | No different | Jul 2022 – Jun 2024 |
| Hospital return days for heart failure patientsUnplanned return visits | 113.4 · 27 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 48.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.5 to 17.7) · 186 cases | No different | Jan 2022 – Dec 2024 |
Original Medicare doctor bills
$279,054
Medicare paid this office $279,054 for 1,264 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 262 | $74,109 | $283 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 262 | $39,818 | $76 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 240 | $34,173 | $142 |
| Return visit (30+ min) | 260 | $29,802 | $83 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 269 | $11,823 | $44 |
See all 31 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 262 | $74,109 | $283 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 262 | $39,818 | $76 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 240 | $34,173 | $142 |
| Return visit (30+ min) | 260 | $29,802 | $83 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 269 | $11,823 | $44 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $9,905 | $129 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 173 | $8,937 | $51 |
| New patient visit (30+ min) | 81 | $6,473 | $80 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 31 | $5,446 | $176 |
| Ultrasound of both sides of head and neck blood flow | 35 | $5,214 | $149 |
| Injection, regadenoson, 0.1 mg | 236 | $4,674 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $4,040 | $59 |
| Long return visit (40+ min) | 29 | $3,561 | $123 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 19 | $3,244 | $171 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 257 | $2,603 | $10 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 50 | $2,195 | $14 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 33 | $1,800 | $17 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 34 | $1,735 | $51 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 203 | $1,393 | $6 |
| New patient visit (60+ min) | 14 | $1,352 | $97 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 18 | $1,302 | $23 |
| Short return visit (20+ min) | 22 | $1,277 | $56 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 27 | $484 | $18 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 16 | $385 | $24 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 42 | $381 | $9 |
| Ultrasound of both sides of head and neck blood flow | 14 | $360 | $26 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 17 | $263 | $15 |
| Ultrasound of heart, follow-up | 11 | $221 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $205 | $16 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 27 | $179 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $135 | $10 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 16 | More than 41% of doctors who do this |
| Pacemaker insertion or repair | 14 | More than 65% of doctors who do this |
Who their Medicare patients are
1,264 Original Medicare patients in 2024. Average age 74 · Under 65 10% · 85 and older 14% · Women 47% · Also on Medicaid 38% · Health risk score 1.76. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 50% · Diabetes 47% · Chronic kidney disease 36% · Atrial fibrillation 34% · Heart failure 31% · Depression 24% · COPD 21% · Cancer 14% · Stroke 10% · Dementia 9%.
The office billed $1,303,675, Medicare allowed $370,790 and paid $279,054; for 4,360 services of 55 kinds; $4,674 of it was for drugs given in the office and $274,381 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,264 | 4,360 | 74 | 1.76 | $1,303,675 | $279,054 |
| 2023 | 1,245 | 4,156 | 74 | 1.68 | $1,247,296 | $316,640 |
| 2022 | 1,348 | 4,280 | 73 | 1.76 | $1,259,133 | $322,850 |
| 2021 | 1,312 | 4,221 | 73 | 1.62 | $1,283,197 | $350,055 |
| 2020 | 1,274 | 3,888 | 73 | 1.75 | $1,180,332 | $322,920 |
| 2019 | 1,536 | 4,811 | 73 | 1.82 | $1,525,796 | $407,821 |
| 2018 | 1,469 | 5,014 | 73 | 1.71 | $1,667,439 | $430,365 |
| 2017 | 1,452 | 4,750 | 73 | 1.76 | $1,474,074 | $393,542 |
| 2016 | 1,216 | 4,334 | 73 | 1.65 | $1,500,140 | $392,795 |
| 2015 | 1,264 | 4,398 | 73 | 1.68 | $1,507,802 | $407,135 |
| 2014 | 1,278 | 4,777 | 72 | 1.57 | $1,674,581 | $434,599 |
| 2013 | 1,186 | 4,410 | 72 | 1.46 | $1,535,361 | $391,120 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 30 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 217 | $63,534 | $289 |
| Return visit (30+ min) | 328 | $44,236 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 222 | $33,608 | $151 |
| Injection, regadenoson, 0.1 mg | 199 | $33,590 | None |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 217 | $32,972 | $75 |
| New patient visit (60+ min) | 126 | $19,106 | $152 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $10,898 | $131 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 223 | $10,375 | $46 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 45 | $8,717 | $194 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 156 | $8,136 | $52 |
| Ultrasound of both sides of head and neck blood flow | 39 | $5,874 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $3,926 | $59 |
| Long return visit (40+ min) | 28 | $3,250 | $116 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 14 | $3,001 | $214 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 237 | $2,549 | $10 |
| Ultrasound of leg arteries or artery grafts | 13 | $2,517 | $194 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 50 | $2,073 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 38 | $1,900 | $19 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 39 | $1,830 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 197 | $1,435 | $6 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $876 | $22 |
| Programming of dual lead pacemaker system | 11 | $587 | $45 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 64 | $580 | $9 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 21 | $523 | $25 |
| Ultrasound of both sides of head and neck blood flow | 12 | $345 | $29 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 17 | $320 | $16 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 15 | $275 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $209 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $138 | $11 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 15 | $100 | $7 |
2022: 27 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 204 | $60,987 | $299 |
| Return visit (30+ min) | 326 | $45,121 | $86 |
| Injection, regadenoson, 0.1 mg | 194 | $35,255 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 226 | $34,345 | $151 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 202 | $32,937 | $82 |
| New patient visit (60+ min) | 111 | $16,535 | $149 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 95 | $14,940 | $149 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 189 | $10,446 | $54 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 208 | $8,995 | $43 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 44 | $8,501 | $193 |
| Ultrasound of both sides of head and neck blood flow | 32 | $4,958 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $3,388 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 280 | $3,002 | $10 |
| Long return visit (40+ min) | 21 | $2,878 | $137 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 64 | $2,506 | $15 |
| Ultrasound of leg arteries or artery grafts | 11 | $2,188 | $199 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 45 | $2,084 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 268 | $2,074 | $6 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 35 | $1,817 | $52 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 20 | $1,249 | $24 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 34 | $876 | $26 |
| Ultrasound of both sides of head and neck blood flow | 22 | $685 | $30 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 58 | $561 | $10 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 24 | $411 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $234 | $17 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $217 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $157 | $11 |
2021: 31 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 219 | $74,032 | $333 |
| Return visit (30+ min) | 316 | $40,374 | $93 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 220 | $38,646 | $87 |
| Injection, regadenoson, 0.1 mg | 203 | $38,570 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 227 | $37,364 | $163 |
| New patient visit (60+ min) | 71 | $11,269 | $159 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 226 | $10,667 | $47 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 45 | $9,329 | $207 |
| Long return visit (40+ min) | 70 | $9,122 | $130 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $8,967 | $160 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 135 | $7,713 | $56 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $6,306 | $420 |
| Ultrasound of both sides of head and neck blood flow | 33 | $5,313 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $4,008 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 287 | $3,311 | $11 |
| New patient visit (45+ min) | 27 | $3,123 | $116 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 56 | $3,098 | $55 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 58 | $2,814 | $17 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 40 | $2,114 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 244 | $1,882 | $7 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 20 | $1,392 | $25 |
| Ultrasound of both sides of head and neck blood flow | 23 | $708 | $31 |
| Short return visit (20+ min) | 14 | $623 | $44 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 59 | $599 | $10 |
| Ultrasound of leg arteries or artery grafts | 13 | $426 | $30 |
| Ultrasound of heart, follow-up | 19 | $388 | $20 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 14 | $377 | $27 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 18 | $314 | $17 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 15 | $291 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $228 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $152 | $12 |
2020: 27 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 204 | $68,491 | $334 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 204 | $35,751 | $87 |
| Injection, regadenoson, 0.1 mg | 181 | $33,760 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 207 | $32,890 | $156 |
| Return visit (30+ min) | 298 | $32,076 | $75 |
| New patient visit (60+ min) | 98 | $14,770 | $151 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $10,631 | $164 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 215 | $10,369 | $48 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 138 | $8,536 | $61 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 35 | $7,095 | $203 |
| Long return visit (40+ min) | 56 | $4,954 | $87 |
| Ultrasound of both sides of head and neck blood flow | 29 | $4,742 | $164 |
| Short return visit (20+ min) | 57 | $3,718 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $3,233 | $59 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 47 | $3,000 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 225 | $2,926 | $13 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 58 | $2,465 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 215 | $1,814 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 38 | $1,754 | $21 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 20 | $1,420 | $27 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 53 | $537 | $10 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 17 | $482 | $28 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $452 | $32 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 23 | $386 | $17 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 17 | $374 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $350 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $234 | $12 |
2019: 34 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 256 | $88,448 | $344 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 257 | $45,519 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 275 | $45,107 | $162 |
| Injection, regadenoson, 0.1 mg | 233 | $42,405 | None |
| Return visit (30+ min) | 350 | $40,456 | $81 |
| New patient visit (60+ min) | 116 | $18,131 | $156 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 261 | $13,139 | $50 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 201 | $12,554 | $61 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $12,210 | $470 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $11,461 | $166 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 57 | $11,402 | $197 |
| Long return visit (40+ min) | 84 | $9,519 | $111 |
| Ultrasound of both sides of head and neck blood flow | 53 | $8,427 | $156 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 339 | $4,548 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $4,301 | $60 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 65 | $4,235 | $64 |
| Ultrasound of leg arteries or artery grafts | 15 | $3,174 | $212 |
| New patient visit (45+ min) | 26 | $2,778 | $107 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 245 | $1,942 | $7 |
| Short return visit (20+ min) | 38 | $1,832 | $47 |
| Programming of dual lead pacemaker system | 27 | $1,546 | $43 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $1,451 | $32 |
| Complete ultrasound study of arm and leg arteries | 14 | $1,307 | $93 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 19 | $1,219 | $31 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 39 | $1,186 | $20 |
| Ultrasound of both sides of head and neck blood flow | 31 | $1,022 | $33 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 74 | $770 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 30 | $554 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 20 | $508 | $24 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 13 | $396 | $28 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 30 | $371 | $12 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 20 | $370 | $19 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $204 | $19 |
| Injection, aminophyllin, up to 250 mg | 13 | $85 | None |
2018: 36 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 274 | $94,056 | $343 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 274 | $47,097 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 258 | $43,194 | $166 |
| Injection, regadenoson, 0.1 mg | 247 | $43,157 | None |
| Return visit (30+ min) | 339 | $40,213 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 103 | $17,538 | $164 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 30 | $14,732 | $446 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 287 | $13,556 | $47 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 71 | $13,132 | $185 |
| New patient visit (60+ min) | 74 | $11,562 | $156 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 190 | $11,526 | $60 |
| Long return visit (40+ min) | 75 | $8,287 | $105 |
| Ultrasound of both sides of head and neck blood flow | 38 | $6,362 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $6,189 | $58 |
| New patient visit (45+ min) | 48 | $5,844 | $122 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,408 | $416 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 73 | $4,765 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 318 | $4,232 | $13 |
| Short return visit (20+ min) | 77 | $4,168 | $51 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 12 | $2,286 | $190 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 259 | $2,220 | $7 |
| Complete ultrasound study of arm and leg arteries | 16 | $1,703 | $106 |
| Programming of dual lead pacemaker system | 35 | $1,643 | $34 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $1,117 | $43 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 34 | $917 | $21 |
| Hospital observation care on day of discharge | 16 | $907 | $57 |
| Ultrasound of both sides of head and neck blood flow | 28 | $905 | $32 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 29 | $525 | $18 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 45 | $454 | $10 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 16 | $444 | $28 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $443 | $32 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $398 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 29 | $352 | $12 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 14 | $276 | $18 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 14 | $272 | $18 |
| Injection, aminophyllin, up to 250 mg | 13 | $73 | None |
2017: 32 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 273 | $92,308 | $338 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 275 | $46,777 | $85 |
| Injection, regadenoson, 0.1 mg | 251 | $43,472 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 232 | $41,368 | $176 |
| Return visit (30+ min) | 203 | $19,765 | $75 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 101 | $16,930 | $160 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 280 | $14,019 | $50 |
| Short return visit (20+ min) | 186 | $11,713 | $53 |
| Ultrasound of both sides of head and neck blood flow | 62 | $9,626 | $155 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $9,502 | $432 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 47 | $9,077 | $189 |
| Long return visit (40+ min) | 79 | $8,400 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 162 | $8,228 | $50 |
| New patient visit (45+ min) | 67 | $7,917 | $118 |
| New patient visit (60+ min) | 49 | $7,642 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $7,063 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 324 | $4,354 | $13 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 62 | $3,817 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 214 | $1,730 | $7 |
| Programming of dual lead pacemaker system | 30 | $1,508 | $39 |
| Ultrasound of both sides of head and neck blood flow | 32 | $996 | $31 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $992 | $47 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 24 | $644 | $20 |
| Hospital observation care on day of discharge | 11 | $640 | $58 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 35 | $612 | $17 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $591 | $31 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 16 | $442 | $28 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 35 | $409 | $12 |
| Injection, aminophyllin, up to 250 mg | 59 | $389 | None |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 18 | $336 | $18 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 16 | $333 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 12 | $298 | $25 |
2016: 30 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 263 | $90,032 | $342 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 263 | $45,260 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 212 | $38,304 | $180 |
| Injection, regadenoson, 0.1 mg | 228 | $38,041 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 116 | $19,042 | $163 |
| Return visit (30+ min) | 172 | $15,240 | $75 |
| Long return visit (40+ min) | 153 | $14,754 | $92 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 275 | $13,587 | $49 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 65 | $13,441 | $207 |
| Short return visit (20+ min) | 155 | $10,600 | $58 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $10,587 | $460 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 176 | $9,152 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 93 | $9,003 | $58 |
| New patient visit (60+ min) | 50 | $7,609 | $152 |
| Ultrasound of both sides of head and neck blood flow | 42 | $6,692 | $156 |
| New patient visit (45+ min) | 47 | $6,037 | $128 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 300 | $4,111 | $13 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 17 | $3,399 | $200 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 47 | $3,115 | $66 |
| Complete ultrasound study of arm and leg arteries | 16 | $1,850 | $116 |
| Programming of dual lead pacemaker system | 24 | $1,537 | $39 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $1,178 | $32 |
| Ultrasound of both sides of head and neck blood flow | 26 | $847 | $33 |
| Hospital observation care on day of discharge | 13 | $770 | $59 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 29 | $528 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 15 | $507 | $20 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 21 | $384 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 30 | $356 | $12 |
| Injection, aminophyllin, up to 250 mg | 48 | $320 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 27 | $235 | $7 |
2015: 31 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 244 | $84,207 | $345 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 244 | $42,361 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 220 | $40,779 | $185 |
| Injection, regadenoson, 0.1 mg | 216 | $35,586 | None |
| Long return visit (40+ min) | 214 | $29,459 | $107 |
| Return visit (30+ min) | 223 | $21,721 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 121 | $20,758 | $165 |
| New patient visit (60+ min) | 96 | $14,766 | $154 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 68 | $14,271 | $207 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 251 | $13,404 | $53 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 22 | $11,375 | $455 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 202 | $10,705 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 103 | $9,473 | $58 |
| Ultrasound of both sides of head and neck blood flow | 49 | $8,173 | $167 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 320 | $4,967 | $13 |
| Short return visit (20+ min) | 56 | $3,055 | $54 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 37 | $2,481 | $67 |
| Programming of dual lead pacemaker system | 33 | $2,054 | $40 |
| New patient visit (45+ min) | 15 | $1,994 | $133 |
| Programming of multiple lead implantable defibrillator system | 12 | $1,619 | $67 |
| Complete ultrasound study of arm and leg arteries | 15 | $1,426 | $95 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $1,267 | $32 |
| Ultrasound of both sides of head and neck blood flow | 39 | $1,258 | $32 |
| Hospital observation care on day of discharge | 17 | $1,067 | $59 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $990 | $43 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 43 | $784 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 43 | $511 | $12 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 16 | $454 | $28 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 13 | $438 | $18 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 21 | $384 | $18 |
| Injection, aminophyllin, up to 250 mg | 30 | $163 | None |
2014: 33 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 286 | $98,173 | $342 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 287 | $50,177 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 232 | $43,752 | $185 |
| Injection, regadenoson, 0.1 mg | 256 | $42,531 | None |
| Return visit (30+ min) | 266 | $30,374 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 117 | $20,009 | $161 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 36 | $19,674 | $468 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 294 | $15,054 | $51 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 70 | $13,908 | $196 |
| Long return visit (40+ min) | 118 | $13,227 | $98 |
| Ultrasound of both sides of head and neck blood flow | 60 | $9,311 | $155 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 154 | $8,062 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 83 | $7,676 | $58 |
| New patient visit (60+ min) | 46 | $7,404 | $161 |
| New patient visit (45+ min) | 49 | $6,001 | $122 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 330 | $5,146 | $13 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $3,932 | $281 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 13 | $3,107 | $222 |
| Short return visit (20+ min) | 56 | $2,976 | $52 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 39 | $2,339 | $58 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 47 | $2,337 | $32 |
| Complete ultrasound study of arm and leg arteries | 15 | $1,695 | $113 |
| Hospital observation care on day of discharge | 25 | $1,583 | $59 |
| Programming of dual lead pacemaker system | 22 | $1,270 | $40 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $1,087 | $52 |
| Ultrasound of both sides of head and neck blood flow | 35 | $853 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 46 | $817 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 46 | $538 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 16 | $523 | $21 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 28 | $510 | $18 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 15 | $425 | $28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 50 | $381 | $7 |
| Injection, aminophyllin, up to 250 mg | 46 | $109 | None |
2013: 33 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 255 | $91,728 | $358 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 257 | $44,643 | $87 |
| Injection, regadenoson, 0.1 mg | 222 | $37,028 | None |
| Return visit (30+ min) | 276 | $28,957 | $76 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 180 | $27,428 | $152 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 36 | $18,670 | $424 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 107 | $17,174 | $156 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 267 | $14,390 | $53 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 71 | $12,838 | $176 |
| Long return visit (40+ min) | 107 | $12,506 | $103 |
| New patient visit (60+ min) | 52 | $7,463 | $144 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 148 | $7,437 | $49 |
| Ultrasound of both sides of head and neck blood flow | 47 | $7,197 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 88 | $7,050 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 330 | $5,498 | $14 |
| New patient visit (45+ min) | 48 | $5,486 | $114 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 59 | $3,763 | $64 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,640 | $303 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 68 | $3,553 | $31 |
| Short return visit (20+ min) | 51 | $2,773 | $53 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 12 | $2,455 | $189 |
| Complete ultrasound study of arm and leg arteries | 17 | $1,960 | $115 |
| Hospital observation care on day of discharge | 24 | $1,505 | $56 |
| Programming of dual lead pacemaker system | 22 | $1,287 | $44 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 11 | $1,081 | $98 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 46 | $802 | $17 |
| Hospital discharge day management, 30 minutes or less | 13 | $748 | $58 |
| Ultrasound of both sides of head and neck blood flow | 30 | $695 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 46 | $533 | $12 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 27 | $484 | $17 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 14 | $400 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 38 | $275 | $6 |
| Injection, aminophyllin, up to 250 mg | 21 | $16 | None |
Medicaid work
$247,898 in 2024
Medicaid paid $247,898 for 2,351 billed services this clinician did in 2024, up to 67 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 550 | $68,190 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 169 | $45,239 |
| Injection, regadenoson, 0.1 mg | 163 | $37,029 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 182 | $30,950 |
| CARDIOVASCULAR STRESS TEST | 221 | $20,634 |
| New patient visit (30+ min) | 219 | $15,651 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 427 | $13,047 |
| Return visit (30+ min) | 203 | $8,755 |
| New patient visit (60+ min) | 53 | $5,933 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 50 | $1,354 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 114 | $1,115 |
| 2024 | 2,351 | 11 | 67 | $247,898 |
| 2023 | 3,135 | 11 | 57 | $320,501 |
| 2022 | 3,159 | 11 | 57 | $340,354 |
| 2021 | 2,990 | 12 | 52 | $299,977 |
| 2020 | 2,574 | 12 | 62 | $254,373 |
| 2019 | 3,047 | 14 | 61 | $276,222 |
| 2018 | 2,583 | 13 | 50 | $227,903 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 620 | $76,956 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 232 | $55,929 |
| Injection, regadenoson, 0.1 mg | 198 | $41,186 |
| CARDIOVASCULAR STRESS TEST | 324 | $39,613 |
| New patient visit (60+ min) | 389 | $37,013 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 247 | $36,787 |
| Return visit (30+ min) | 442 | $16,119 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 501 | $14,285 |
| 1ST HOSP IP/OBS HIGH 75 | 18 | $1,066 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 139 | $1,019 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 25 | $527 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 609 | $75,206 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 222 | $57,674 |
| CARDIOVASCULAR STRESS TEST | 294 | $53,039 |
| Injection, regadenoson, 0.1 mg | 215 | $47,235 |
| New patient visit (60+ min) | 383 | $37,289 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 225 | $36,922 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 541 | $13,776 |
| Return visit (30+ min) | 382 | $13,275 |
| New patient visit (45+ min) | 33 | $2,452 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 240 | $1,820 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 15 | $1,665 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 674 | $90,299 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 217 | $48,005 |
| CARDIOVASCULAR STRESS TEST | 274 | $39,960 |
| Injection, regadenoson, 0.1 mg | 194 | $36,370 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 223 | $31,418 |
| New patient visit (60+ min) | 212 | $20,640 |
| Return visit (30+ min) | 342 | $11,363 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 476 | $11,266 |
| New patient visit (45+ min) | 76 | $6,741 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 274 | $2,690 |
| Long return visit (40+ min) | 16 | $995 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 12 | $230 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 571 | $66,580 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 190 | $47,158 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 189 | $30,183 |
| Injection, regadenoson, 0.1 mg | 143 | $28,904 |
| CARDIOVASCULAR STRESS TEST | 228 | $28,382 |
| New patient visit (60+ min) | 280 | $27,365 |
| Return visit (30+ min) | 357 | $12,098 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 419 | $10,927 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 157 | $1,219 |
| Long return visit (40+ min) | 16 | $751 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $649 |
| Short return visit (20+ min) | 12 | $158 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 611 | $66,395 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 230 | $49,209 |
| Injection, regadenoson, 0.1 mg | 206 | $37,004 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 232 | $34,870 |
| CARDIOVASCULAR STRESS TEST | 266 | $34,738 |
| New patient visit (60+ min) | 226 | $19,097 |
| Return visit (30+ min) | 430 | $13,921 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 476 | $11,302 |
| Long return visit (40+ min) | 57 | $2,836 |
| New patient visit (45+ min) | 33 | $2,705 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 242 | $1,840 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 12 | $1,317 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 601 | $67,400 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 183 | $36,758 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 179 | $26,574 |
| CARDIOVASCULAR STRESS TEST | 237 | $23,846 |
| Injection, regadenoson, 0.1 mg | 133 | $21,752 |
| New patient visit (60+ min) | 183 | $20,203 |
| Return visit (30+ min) | 311 | $11,563 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 396 | $10,272 |
| Long return visit (40+ min) | 37 | $2,356 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 24 | $2,326 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 260 | $2,170 |
| New patient visit (45+ min) | 26 | $1,924 |
Drugs they prescribed that Part D paid
$859,695
Pharmacies billed $859,695 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,387) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
2,366 generic and 1,021 brand-name prescriptions · $859,695 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 636 | $534,585 | $841 |
| Xarelto | 106 | $106,342 | $1,003 |
| Jardiance | 45 | $36,314 | $807 |
| Entresto | 35 | $32,084 | $917 |
| Brilinta | 59 | $28,458 | $482 |
See all 36 drugs
| Eliquis | 636 | $534,585 | $841 |
| Xarelto | 106 | $106,342 | $1,003 |
| Jardiance | 45 | $36,314 | $807 |
| Entresto | 35 | $32,084 | $917 |
| Brilinta | 59 | $28,458 | $482 |
| Metoprolol | 380 | $4,706 | $12 |
| Atorvastatin | 236 | $3,934 | $17 |
| Diltiazem 24hr Er | 84 | $2,531 | $30 |
| Flecainide Acetate | 100 | $2,361 | $24 |
| Clopidogrel | 157 | $2,341 | $15 |
| Ranolazine Er | 28 | $2,101 | $75 |
| Carvedilol | 170 | $1,840 | $11 |
| Propafenone | 22 | $1,604 | $73 |
| Amiodarone | 158 | $1,521 | $10 |
| Valsartan-Hydrochlorothiazide | 51 | $1,396 | $27 |
| Sotalol | 51 | $1,346 | $26 |
| Lisinopril | 84 | $761 | $9 |
| Amlodipine Besylate | 110 | $748 | $7 |
| Digoxin | 40 | $683 | $17 |
| Furosemide | 111 | $675 | $6 |
| Losartan | 62 | $675 | $11 |
| Rosuvastatin | 40 | $660 | $17 |
| Metoprolol | 90 | $659 | $7 |
| Valsartan | 28 | $653 | $23 |
| Dilt-Xr | 11 | $628 | $57 |
| Bisoprolol | 25 | $488 | $20 |
| Prasugrel | 21 | $428 | $20 |
| Diltiazem 24hr Er (Cd) | 35 | $405 | $12 |
| Warfarin | 63 | $397 | $6 |
| Spironolactone | 51 | $372 | $7 |
| Ezetimibe | 21 | $301 | $14 |
| Nitroglycerin | 31 | $294 | $9 |
| Potassium Chloride | 23 | $219 | $10 |
| Isosorbide Mononitrate Er | 19 | $161 | $8 |
| Hydrochlorothiazide | 34 | $158 | $5 |
| Diltiazem | 17 | $99 | $6 |
Year by year
| 2024 | 3,387 | 569 | 0% (0) | 30% | $859,695 |
| 2023 | 3,219 | 554 | None | None | $750,741 |
| 2022 | 3,284 | 527 | 0% (0) | 26% | $675,472 |
| 2021 | 3,179 | 492 | 0% (0) | 25% | $555,512 |
| 2020 | 3,237 | 478 | 0% (0) | 23% | $455,546 |
| 2019 | 3,284 | 508 | None | 23% | $463,059 |
| 2018 | 3,170 | 482 | None | 19% | $313,938 |
| 2017 | 3,264 | 474 | None | 20% | $262,702 |
| 2016 | 3,590 | 494 | None | None | $293,365 |
| 2015 | 3,572 | 470 | None | None | $238,640 |
| 2014 | 3,852 | 475 | None | None | $213,696 |
| 2013 | 4,270 | 472 | None | None | $223,292 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 39 drugs
| Eliquis | 530 | $443,975 | $838 |
| Xarelto | 110 | $106,904 | $972 |
| Jardiance | 48 | $42,454 | $884 |
| Brilinta | 55 | $34,198 | $622 |
| Entresto | 13 | $14,291 | $1,099 |
| Farxiga | 16 | $12,697 | $794 |
| Metoprolol | 352 | $7,052 | $20 |
| Atorvastatin | 239 | $6,375 | $27 |
| Flecainide Acetate | 82 | $6,208 | $76 |
| Clopidogrel | 203 | $3,891 | $19 |
| Midodrine | 12 | $3,845 | $320 |
| Carvedilol | 244 | $3,779 | $15 |
| Propafenone | 29 | $3,485 | $120 |
| Valsartan-Hydrochlorothiazide | 36 | $2,829 | $79 |
| Diltiazem 24hr Er | 67 | $2,476 | $37 |
| Amiodarone | 119 | $2,416 | $20 |
| Diltiazem 12hr Er | 13 | $2,026 | $156 |
| Diltiazem 24hr Er (Cd) | 30 | $1,718 | $57 |
| Sotalol | 26 | $1,642 | $63 |
| Valsartan | 31 | $1,523 | $49 |
| Warfarin | 66 | $1,487 | $23 |
| Losartan | 69 | $1,487 | $22 |
| Lisinopril | 91 | $1,354 | $15 |
| Digoxin | 41 | $1,338 | $33 |
| Bisoprolol | 24 | $1,273 | $53 |
| Diltiazem 24hr Er (Xr) | 23 | $1,240 | $54 |
| Amlodipine Besylate | 86 | $1,140 | $13 |
| Rosuvastatin | 35 | $1,008 | $29 |
| Metoprolol | 83 | $798 | $10 |
| Verapamil Er | 12 | $797 | $66 |
| Furosemide | 101 | $516 | $5 |
| Spironolactone | 40 | $511 | $13 |
| Ezetimibe | 16 | $454 | $28 |
| Nitroglycerin | 18 | $393 | $22 |
| Dilt-Xr | 13 | $364 | $28 |
| Potassium Chloride | 12 | $253 | $21 |
| Atenolol | 12 | $192 | $16 |
| Hydrochlorothiazide | 21 | $163 | $8 |
| Lisinopril-Hydrochlorothiazide | 11 | $157 | $14 |
2022: 44 drugs
| Eliquis | 480 | $390,549 | $814 |
| Xarelto | 84 | $70,164 | $835 |
| Brilinta | 107 | $58,083 | $543 |
| Pradaxa | 36 | $22,030 | $612 |
| Jardiance | 32 | $20,802 | $650 |
| Prasugrel | 40 | $8,311 | $208 |
| Repatha Sureclick | 14 | $7,605 | $543 |
| Metoprolol | 358 | $5,952 | $17 |
| Flecainide Acetate | 59 | $4,922 | $83 |
| Atorvastatin | 238 | $4,545 | $19 |
| Propafenone | 32 | $3,940 | $123 |
| Carvedilol | 268 | $3,662 | $14 |
| Valsartan-Hydrochlorothiazide | 43 | $3,568 | $83 |
| Midodrine | 12 | $3,295 | $275 |
| Clopidogrel | 157 | $2,956 | $19 |
| Ranolazine Er | 21 | $2,875 | $137 |
| Diltiazem 24hr Er (Cd) | 36 | $2,272 | $63 |
| Diltiazem 24hr Er | 54 | $2,067 | $38 |
| Amiodarone | 90 | $1,744 | $19 |
| Bisoprolol | 43 | $1,632 | $38 |
| Digoxin | 43 | $1,629 | $38 |
| Warfarin | 62 | $1,550 | $25 |
| Diltiazem 12hr Er | 11 | $1,531 | $139 |
| Sotalol | 24 | $1,476 | $61 |
| Lisinopril | 119 | $1,203 | $10 |
| Valsartan | 16 | $1,138 | $71 |
| Rosuvastatin | 39 | $1,052 | $27 |
| Diltiazem 24hr Er (Xr) | 21 | $1,050 | $50 |
| Metoprolol | 110 | $959 | $9 |
| Losartan | 63 | $881 | $14 |
| Verapamil Er | 12 | $850 | $71 |
| Dilt-Xr | 15 | $756 | $50 |
| Amlodipine Besylate | 91 | $653 | $7 |
| Furosemide | 102 | $616 | $6 |
| Potassium Chloride | 32 | $577 | $18 |
| Spironolactone | 37 | $517 | $14 |
| Ezetimibe | 14 | $435 | $31 |
| Nitroglycerin | 17 | $432 | $25 |
| Isosorbide Mononitrate Er | 17 | $419 | $25 |
| Losartan-Hydrochlorothiazide | 11 | $204 | $19 |
| Hydrochlorothiazide | 34 | $162 | $5 |
| Lisinopril-Hydrochlorothiazide | 17 | $131 | $8 |
| Atenolol | 13 | $90 | $7 |
| Ramipril | 12 | $76 | $6 |
2021: 40 drugs
| Eliquis | 459 | $292,638 | $638 |
| Xarelto | 79 | $61,437 | $778 |
| Brilinta | 47 | $24,403 | $519 |
| Pradaxa | 41 | $24,369 | $594 |
| Repatha Sureclick | 13 | $7,196 | $554 |
| Flecainide Acetate | 66 | $6,087 | $92 |
| Metoprolol | 291 | $5,452 | $19 |
| Prasugrel | 30 | $4,214 | $140 |
| Carvedilol | 323 | $3,140 | $10 |
| Ranolazine Er | 17 | $2,905 | $171 |
| Propafenone | 26 | $2,868 | $110 |
| Atorvastatin | 210 | $2,586 | $12 |
| Amiodarone | 76 | $2,197 | $29 |
| Diltiazem 24hr Er (Cd) | 50 | $1,932 | $39 |
| Clopidogrel | 192 | $1,859 | $10 |
| Midodrine | 13 | $1,437 | $111 |
| Dilt-Xr | 19 | $1,351 | $71 |
| Digoxin | 29 | $1,294 | $45 |
| Warfarin | 74 | $1,278 | $17 |
| Losartan | 91 | $1,186 | $13 |
| Potassium Chloride | 42 | $1,148 | $27 |
| Sotalol | 27 | $1,073 | $40 |
| Valsartan | 15 | $1,019 | $68 |
| Rosuvastatin | 29 | $971 | $33 |
| Metoprolol | 115 | $960 | $8 |
| Diltiazem 24hr Er | 19 | $933 | $49 |
| Lisinopril | 124 | $919 | $7 |
| Bisoprolol | 21 | $898 | $43 |
| Valsartan-Hydrochlorothiazide | 11 | $894 | $81 |
| Amlodipine Besylate | 93 | $857 | $9 |
| Furosemide | 154 | $742 | $5 |
| Nitroglycerin | 33 | $632 | $19 |
| Bumetanide | 11 | $465 | $42 |
| Isosorbide Mononitrate Er | 23 | $410 | $18 |
| Spironolactone | 34 | $383 | $11 |
| Lisinopril-Hydrochlorothiazide | 13 | $186 | $14 |
| Hydrochlorothiazide | 47 | $163 | $3 |
| Atenolol | 16 | $149 | $9 |
| Simvastatin | 12 | $108 | $9 |
| Ramipril | 11 | $44 | $4 |
2020: 39 drugs
| Eliquis | 408 | $259,603 | $636 |
| Xarelto | 60 | $54,091 | $902 |
| Pradaxa | 50 | $25,612 | $512 |
| Brilinta | 45 | $19,093 | $424 |
| Repatha Sureclick | 19 | $8,870 | $467 |
| Flecainide Acetate | 68 | $5,397 | $79 |
| Metoprolol | 259 | $5,057 | $20 |
| Propafenone | 43 | $4,425 | $103 |
| Prasugrel | 26 | $3,929 | $151 |
| Atorvastatin | 246 | $3,146 | $13 |
| Midodrine | 11 | $3,110 | $283 |
| Ranolazine Er | 19 | $2,887 | $152 |
| Carvedilol | 285 | $2,750 | $10 |
| Clopidogrel | 241 | $2,627 | $11 |
| Digoxin | 42 | $2,288 | $54 |
| Potassium Chloride | 57 | $2,029 | $36 |
| Amiodarone | 95 | $1,958 | $21 |
| Metoprolol | 153 | $1,248 | $8 |
| Sotalol | 22 | $1,244 | $57 |
| Dilt-Xr | 17 | $1,243 | $73 |
| Losartan | 112 | $1,213 | $11 |
| Diltiazem 24hr Er | 31 | $1,143 | $37 |
| Warfarin | 56 | $1,011 | $18 |
| Furosemide | 149 | $972 | $7 |
| Amlodipine Besylate | 103 | $863 | $8 |
| Diltiazem 24hr Er (Cd) | 23 | $819 | $36 |
| Rosuvastatin | 23 | $770 | $33 |
| Cartia Xt | 22 | $727 | $33 |
| Lisinopril | 97 | $695 | $7 |
| Olmesartan-Hydrochlorothiazide | 19 | $688 | $36 |
| Enalapril Maleate | 19 | $613 | $32 |
| Valsartan-Hydrochlorothiazide | 13 | $613 | $47 |
| Nitroglycerin | 29 | $564 | $19 |
| Isosorbide Mononitrate Er | 20 | $340 | $17 |
| Lisinopril-Hydrochlorothiazide | 15 | $263 | $18 |
| Hydrochlorothiazide | 69 | $220 | $3 |
| Spironolactone | 33 | $206 | $6 |
| Simvastatin | 27 | $203 | $8 |
| Atenolol | 16 | $190 | $12 |
2019: 41 drugs
| Eliquis | 361 | $208,080 | $576 |
| Xarelto | 94 | $70,186 | $747 |
| Brilinta | 78 | $37,990 | $487 |
| Pradaxa | 42 | $21,630 | $515 |
| Multaq | 12 | $8,301 | $692 |
| Prasugrel | 42 | $6,596 | $157 |
| Repatha Sureclick | 13 | $6,260 | $482 |
| Flecainide Acetate | 98 | $6,087 | $62 |
| Metoprolol | 219 | $5,893 | $27 |
| Atorvastatin | 247 | $4,689 | $19 |
| Propafenone | 48 | $4,000 | $83 |
| Carvedilol | 299 | $3,570 | $12 |
| Clopidogrel | 231 | $3,297 | $14 |
| Midodrine | 12 | $2,913 | $243 |
| Amiodarone | 132 | $2,643 | $20 |
| Nadolol | 16 | $2,071 | $129 |
| Potassium Chloride | 46 | $1,743 | $38 |
| Digoxin | 37 | $1,672 | $45 |
| Rosuvastatin | 34 | $1,590 | $47 |
| Sotalol | 43 | $1,414 | $33 |
| Metoprolol | 144 | $1,327 | $9 |
| Diltiazem 24hr Er | 29 | $1,282 | $44 |
| Cartia Xt | 33 | $1,168 | $35 |
| Lisinopril | 99 | $1,038 | $10 |
| Furosemide | 138 | $1,008 | $7 |
| Dilt-Xr | 13 | $964 | $74 |
| Enalapril Maleate | 20 | $926 | $46 |
| Losartan | 72 | $925 | $13 |
| Warfarin | 60 | $793 | $13 |
| Amlodipine Besylate | 98 | $754 | $8 |
| Digox | 12 | $699 | $58 |
| Nitroglycerin | 28 | $690 | $25 |
| Olmesartan-Hydrochlorothiazide | 24 | $527 | $22 |
| Chlorthalidone | 14 | $509 | $36 |
| Isosorbide Mononitrate Er | 26 | $455 | $18 |
| Spironolactone | 40 | $395 | $10 |
| Simvastatin | 27 | $317 | $12 |
| Hydrochlorothiazide | 84 | $281 | $3 |
| Lisinopril-Hydrochlorothiazide | 14 | $230 | $16 |
| Atenolol | 16 | $173 | $11 |
| Lovastatin | 12 | $155 | $13 |
2018: 43 drugs
| Eliquis | 297 | $144,877 | $488 |
| Brilinta | 72 | $27,555 | $383 |
| Pradaxa | 47 | $25,745 | $548 |
| Xarelto | 29 | $24,279 | $837 |
| Ranexa | 18 | $14,525 | $807 |
| Metoprolol | 253 | $6,690 | $26 |
| Entresto | 12 | $5,885 | $490 |
| Flecainide Acetate | 80 | $5,462 | $68 |
| Prasugrel | 17 | $5,005 | $294 |
| Atorvastatin | 233 | $4,435 | $19 |
| Clopidogrel | 251 | $3,742 | $15 |
| Carvedilol | 346 | $3,256 | $9 |
| Propafenone | 53 | $3,186 | $60 |
| Diltiazem 24hr Er (Cd) | 14 | $2,981 | $213 |
| Nadolol | 22 | $2,404 | $109 |
| Digox | 28 | $2,126 | $76 |
| Amiodarone | 70 | $1,680 | $24 |
| Metoprolol | 180 | $1,520 | $8 |
| Lisinopril | 145 | $1,401 | $10 |
| Sotalol | 63 | $1,398 | $22 |
| Potassium Chloride | 47 | $1,218 | $26 |
| Losartan | 70 | $937 | $13 |
| Warfarin | 66 | $927 | $14 |
| Diltiazem 24hr Er | 20 | $923 | $46 |
| Amlodipine Besylate | 121 | $858 | $7 |
| Rosuvastatin | 30 | $842 | $28 |
| Nitroglycerin | 27 | $716 | $27 |
| Dilt-Xr | 22 | $709 | $32 |
| Digoxin | 13 | $705 | $54 |
| Isosorbide Mononitrate Er | 38 | $675 | $18 |
| Valsartan-Hydrochlorothiazide | 14 | $663 | $47 |
| Furosemide | 86 | $653 | $8 |
| Chlorthalidone | 14 | $620 | $44 |
| Enalapril Maleate | 14 | $478 | $34 |
| Cartia Xt | 11 | $475 | $43 |
| Valsartan | 13 | $320 | $25 |
| Simvastatin | 33 | $286 | $9 |
| Hydrochlorothiazide | 77 | $282 | $4 |
| Spironolactone | 34 | $266 | $8 |
| Nifedipine Er | 11 | $224 | $20 |
| Propranolol | 13 | $218 | $17 |
| Atenolol | 19 | $206 | $11 |
| Lovastatin | 16 | $125 | $8 |
2017: 38 drugs
| Eliquis | 203 | $92,155 | $454 |
| Xarelto | 34 | $26,636 | $783 |
| Brilinta | 60 | $24,594 | $410 |
| Pradaxa | 40 | $19,779 | $494 |
| Ranexa | 23 | $19,523 | $849 |
| Effient | 39 | $17,336 | $445 |
| Metoprolol | 270 | $6,515 | $24 |
| Flecainide Acetate | 104 | $5,233 | $50 |
| Atorvastatin | 265 | $3,446 | $13 |
| Clopidogrel | 297 | $3,229 | $11 |
| Propafenone | 34 | $2,315 | $68 |
| Carvedilol | 334 | $2,235 | $7 |
| Rosuvastatin | 22 | $1,710 | $78 |
| Potassium Chloride | 47 | $1,558 | $33 |
| Digox | 22 | $1,532 | $70 |
| Metoprolol | 207 | $1,352 | $7 |
| Isosorbide Mononitrate Er | 85 | $1,310 | $15 |
| Digoxin | 40 | $1,276 | $32 |
| Diltiazem 24hr Er | 37 | $1,178 | $32 |
| Amiodarone | 74 | $1,066 | $14 |
| Chlorthalidone | 26 | $952 | $37 |
| Lisinopril | 108 | $881 | $8 |
| Warfarin | 64 | $781 | $12 |
| Nitroglycerin | 28 | $778 | $28 |
| Valsartan-Hydrochlorothiazide | 29 | $763 | $26 |
| Amlodipine Besylate | 142 | $702 | $5 |
| Sotalol | 36 | $668 | $19 |
| Cartia Xt | 16 | $566 | $35 |
| Pravastatin | 19 | $463 | $24 |
| Furosemide | 104 | $445 | $4 |
| Simvastatin | 44 | $403 | $9 |
| Losartan | 67 | $385 | $6 |
| Hydrochlorothiazide | 80 | $284 | $4 |
| Spironolactone | 36 | $201 | $6 |
| Atenolol | 32 | $174 | $5 |
| Dilt-Xr | 12 | $162 | $14 |
| Lovastatin | 17 | $120 | $7 |
| Cephalexin | 15 | $92 | $6 |
2016: 41 drugs
| Eliquis | 172 | $69,574 | $404 |
| Xarelto | 60 | $30,514 | $509 |
| Effient | 72 | $27,237 | $378 |
| Ranexa | 37 | $24,419 | $660 |
| Pradaxa | 45 | $19,451 | $432 |
| Brilinta | 50 | $18,020 | $360 |
| Corlanor | 17 | $6,523 | $384 |
| Metoprolol | 234 | $5,302 | $23 |
| Atorvastatin | 306 | $4,810 | $16 |
| Clopidogrel | 398 | $4,692 | $12 |
| Flecainide Acetate | 101 | $4,624 | $46 |
| Nexium | 12 | $3,029 | $252 |
| Carvedilol | 344 | $2,282 | $7 |
| Valsartan | 35 | $1,946 | $56 |
| Metoprolol | 221 | $1,828 | $8 |
| Isosorbide Mononitrate Er | 84 | $1,609 | $19 |
| Nitrostat | 34 | $1,556 | $46 |
| Enalapril Maleate | 22 | $1,346 | $61 |
| Lisinopril | 157 | $1,267 | $8 |
| Digoxin | 38 | $1,261 | $33 |
| Digox | 21 | $1,207 | $57 |
| Propafenone | 38 | $1,150 | $30 |
| Chlorthalidone | 31 | $1,107 | $36 |
| Amiodarone | 74 | $1,093 | $15 |
| Sotalol | 46 | $1,031 | $22 |
| Warfarin | 77 | $1,005 | $13 |
| Amlodipine Besylate | 158 | $960 | $6 |
| Valsartan-Hydrochlorothiazide | 34 | $954 | $28 |
| Diltiazem 24hr Er | 39 | $910 | $23 |
| Nitroglycerin | 15 | $852 | $57 |
| Potassium Chloride | 34 | $813 | $24 |
| Losartan | 64 | $508 | $8 |
| Simvastatin | 49 | $483 | $10 |
| Pravastatin | 23 | $398 | $17 |
| Furosemide | 96 | $385 | $4 |
| Hydrochlorothiazide | 52 | $287 | $6 |
| Atenolol | 32 | $259 | $8 |
| Spironolactone | 33 | $250 | $8 |
| Lovastatin | 26 | $175 | $7 |
| Cephalexin | 19 | $147 | $8 |
| Famotidine | 12 | $146 | $12 |
2015: 46 drugs
| Xarelto | 97 | $43,588 | $449 |
| Eliquis | 85 | $29,342 | $345 |
| Effient | 84 | $27,198 | $324 |
| Ranexa | 52 | $22,302 | $429 |
| Pradaxa | 43 | $14,191 | $330 |
| Tikosyn | 11 | $11,303 | $1,028 |
| Brilinta | 32 | $9,343 | $292 |
| Clopidogrel | 448 | $6,791 | $15 |
| Multaq | 13 | $6,383 | $491 |
| Metoprolol | 216 | $5,488 | $25 |
| Nexium | 19 | $4,091 | $215 |
| Flecainide Acetate | 84 | $4,063 | $48 |
| Diovan | 11 | $4,055 | $369 |
| Atorvastatin | 310 | $4,024 | $13 |
| Valsartan | 25 | $2,556 | $102 |
| Propafenone | 49 | $2,299 | $47 |
| Carvedilol | 296 | $2,089 | $7 |
| Benicar Hct | 11 | $1,849 | $168 |
| Warfarin | 97 | $1,664 | $17 |
| Metoprolol | 222 | $1,617 | $7 |
| Potassium Chloride | 59 | $1,279 | $22 |
| Digoxin | 27 | $1,233 | $46 |
| Nitrostat | 53 | $1,118 | $21 |
| Lisinopril | 139 | $1,052 | $8 |
| Enalapril Maleate | 22 | $1,008 | $46 |
| Amiodarone | 84 | $989 | $12 |
| Pravastatin | 40 | $975 | $24 |
| Digox | 15 | $956 | $64 |
| Isosorbide Mononitrate Er | 66 | $926 | $14 |
| Sotalol | 58 | $903 | $16 |
| Valsartan-Hydrochlorothiazide | 27 | $864 | $32 |
| Amlodipine Besylate | 144 | $787 | $5 |
| Diltiazem 24hr Er | 23 | $724 | $31 |
| Cartia Xt | 31 | $671 | $22 |
| Simvastatin | 66 | $648 | $10 |
| Chlorthalidone | 27 | $596 | $22 |
| Furosemide | 94 | $415 | $4 |
| Losartan | 61 | $394 | $6 |
| Spironolactone | 55 | $319 | $6 |
| Lovastatin | 20 | $206 | $10 |
| Diltiazem 24hr Cd | 14 | $188 | $13 |
| Lisinopril-Hydrochlorothiazide | 11 | $178 | $16 |
| Hydrochlorothiazide | 34 | $176 | $5 |
| Atenolol | 33 | $140 | $4 |
| Cephalexin | 16 | $122 | $8 |
| Famotidine | 12 | $104 | $9 |
2014: 43 drugs
| Effient | 153 | $45,503 | $297 |
| Xarelto | 89 | $34,983 | $393 |
| Ranexa | 57 | $20,502 | $360 |
| Eliquis | 37 | $11,368 | $307 |
| Pradaxa | 33 | $10,368 | $314 |
| Crestor | 30 | $8,849 | $295 |
| Metoprolol | 252 | $7,851 | $31 |
| Clopidogrel | 462 | $7,064 | $15 |
| Multaq | 13 | $5,195 | $400 |
| Diovan | 29 | $4,691 | $162 |
| Atorvastatin | 289 | $4,383 | $15 |
| Carvedilol | 375 | $3,605 | $10 |
| Flecainide Acetate | 83 | $3,136 | $38 |
| Midodrine | 23 | $2,886 | $125 |
| Brilinta | 11 | $2,795 | $254 |
| Valsartan | 17 | $2,217 | $130 |
| Metoprolol | 245 | $1,922 | $8 |
| Propafenone | 56 | $1,886 | $34 |
| Potassium Chloride | 58 | $1,598 | $28 |
| Digoxin | 24 | $1,535 | $64 |
| Lisinopril | 199 | $1,406 | $7 |
| Digox | 27 | $1,386 | $51 |
| Valsartan-Hydrochlorothiazide | 26 | $1,240 | $48 |
| Klor-Con 10 | 33 | $1,234 | $37 |
| Warfarin | 93 | $1,228 | $13 |
| Simvastatin | 133 | $1,204 | $9 |
| Amiodarone | 77 | $1,056 | $14 |
| Losartan | 70 | $1,052 | $15 |
| Diltiazem 24hr Er | 40 | $974 | $24 |
| Amlodipine Besylate | 124 | $842 | $7 |
| Isosorbide Dinitrate | 11 | $821 | $75 |
| Nitrostat | 52 | $799 | $15 |
| Furosemide | 152 | $714 | $5 |
| Sotalol | 37 | $690 | $19 |
| Isosorbide Mononitrate Er | 55 | $681 | $12 |
| Lovastatin | 23 | $574 | $25 |
| Pravastatin | 18 | $472 | $26 |
| Atenolol | 33 | $420 | $13 |
| Cartia Xt | 18 | $419 | $23 |
| Enalapril Maleate | 19 | $371 | $20 |
| Chlorthalidone | 15 | $349 | $23 |
| Spironolactone | 50 | $337 | $7 |
| Hydrochlorothiazide | 45 | $336 | $7 |
2013: 49 drugs
| Effient | 113 | $28,396 | $251 |
| Ranexa | 80 | $26,227 | $328 |
| Xarelto | 80 | $24,377 | $305 |
| Pradaxa | 60 | $19,741 | $329 |
| Clopidogrel | 547 | $11,796 | $22 |
| Diovan | 63 | $8,553 | $136 |
| Multaq | 19 | $7,795 | $410 |
| Crestor | 33 | $7,003 | $212 |
| Metoprolol | 190 | $6,384 | $34 |
| Atorvastatin | 201 | $4,686 | $23 |
| Carvedilol | 374 | $4,474 | $12 |
| Brilinta | 15 | $3,673 | $245 |
| Midodrine | 14 | $3,382 | $242 |
| Flecainide Acetate | 102 | $3,086 | $30 |
| Propafenone | 55 | $3,084 | $56 |
| Metoprolol | 313 | $2,285 | $7 |
| Niaspan | 14 | $2,125 | $152 |
| Warfarin | 176 | $2,105 | $12 |
| Bystolic | 27 | $2,071 | $77 |
| Valsartan-Hydrochlorothiazide | 12 | $2,000 | $167 |
| Simvastatin | 193 | $1,944 | $10 |
| Amiodarone | 95 | $1,803 | $19 |
| Lisinopril | 249 | $1,727 | $7 |
| Isosorbide Dinitrate | 20 | $1,681 | $84 |
| Potassium Chloride | 58 | $1,627 | $28 |
| Isosorbide Mononitrate Er | 93 | $1,403 | $15 |
| Losartan | 93 | $1,381 | $15 |
| Amlodipine Besylate | 140 | $1,199 | $9 |
| Klor-Con 10 | 37 | $1,151 | $31 |
| Sotalol | 35 | $1,117 | $32 |
| Nitrostat | 70 | $924 | $13 |
| Lovastatin | 53 | $806 | $15 |
| Furosemide | 143 | $801 | $6 |
| Cartia Xt | 21 | $743 | $35 |
| Spironolactone | 67 | $538 | $8 |
| Diltiazem 24hr Er | 18 | $475 | $26 |
| Hydrochlorothiazide | 85 | $414 | $5 |
| Verapamil Er | 11 | $391 | $36 |
| Pacerone | 20 | $374 | $19 |
| Enalapril Maleate | 26 | $371 | $14 |
| Hydralazine | 11 | $342 | $31 |
| Digox | 25 | $271 | $11 |
| Atenolol | 25 | $232 | $9 |
| Pravastatin | 17 | $224 | $13 |
| Bumetanide | 11 | $201 | $18 |
| Metolazone | 11 | $133 | $12 |
| Terazosin | 12 | $111 | $9 |
| Clonidine | 13 | $78 | $6 |
| Digoxin | 15 | $63 | $4 |
Money from drug and device companies
$7,209 in 2025
| 2025 | 4 | 36 | None | $7,209 |
| 2024 | 3 | 19 | None | $391 |
| 2023 | 5 | 9 | None | $258 |
| 2022 | 7 | 10 | None | $3,930 |
| 2021 | 3 | 7 | None | $129 |
| 2020 | 2 | 4 | None | $66 |
| 2019 | 6 | 17 | None | $286 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AngioDynamics | Auryon Laser System 100-120 Vac | $5,783 | 1 payment
|
| Abbott Laboratories | Aveir | $1,256 | 30 payments
|
| Biotronik | Amvia Edge | $132 | 3 payments
|
| Medtronic | Reveal Linq | $38 | 2 payments
|
See all 36 published payments
| AngioDynamics | Long term medical supply or device loan · 2025-12-31 | Auryon Laser System 100-120 Vac | $5,783 |
| Abbott Laboratories | Meals · 2025-12-30 | Gallant | $26 |
| Abbott Laboratories | Meals · 2025-12-29 | Gallant | $9 |
| Biotronik | Meals · 2025-12-19 | Acticor 7 Vr-T Dx | $33 |
| Abbott Laboratories | Travel · 2025-12-08 | Aveir | $9 |
| Abbott Laboratories | Travel · 2025-12-08 | Aveir | $29 |
| Abbott Laboratories | Travel · 2025-12-08 | Aveir | $167 |
| Abbott Laboratories | Travel · 2025-12-08 | Aveir | $306 |
| Abbott Laboratories | Meals · 2025-11-14 | Aveir | $18 |
| Abbott Laboratories | Meals · 2025-11-14 | Gallant | $22 |
| Abbott Laboratories | Meals · 2025-11-14 | Gallant | $24 |
| Abbott Laboratories | Meals · 2025-11-14 | Gallant | $25 |
| Abbott Laboratories | Meals · 2025-11-14 | Gallant | $26 |
| Biotronik | Meals · 2025-11-10 | Amvia Edge | $73 |
| Abbott Laboratories | Meals · 2025-09-17 | Gallant | $22 |
| Abbott Laboratories | Meals · 2025-09-17 | Gallant | $25 |
| Abbott Laboratories | Meals · 2025-09-04 | Aveir | $156 |
| Biotronik | Meals · 2025-08-29 | Amvia Edge | $25 |
| Abbott Laboratories | Meals · 2025-08-22 | Gallant | $40 |
| Abbott Laboratories | Meals · 2025-07-30 | Gallant | $22 |
| Abbott Laboratories | Meals · 2025-07-30 | Aveir | $23 |
| Medtronic | Meals · 2025-06-25 | Reveal Linq | $21 |
| Abbott Laboratories | Meals · 2025-06-17 | Gallant | $22 |
| Medtronic | Meals · 2025-05-23 | Reveal Linq | $17 |
| Abbott Laboratories | Meals · 2025-05-22 | Gallant | $24 |
| Abbott Laboratories | Meals · 2025-05-22 | Gallant | $32 |
| Abbott Laboratories | Meals · 2025-05-09 | Gallant | $28 |
| Abbott Laboratories | Meals · 2025-04-09 | Gallant | $24 |
| Abbott Laboratories | Meals · 2025-04-09 | Gallant | $25 |
| Abbott Laboratories | Meals · 2025-04-09 | Gallant | $25 |
| Abbott Laboratories | Meals · 2025-03-25 | Aveir | $7 |
| Abbott Laboratories | Meals · 2025-03-25 | Gallant | $19 |
| Abbott Laboratories | Meals · 2025-03-25 | Aveir | $24 |
| Abbott Laboratories | Meals · 2025-03-25 | Gallant | $32 |
| Abbott Laboratories | Meals · 2025-02-28 | Jot Dx | $22 |
| Abbott Laboratories | Meals · 2025-01-01 | Aveir | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $391
| Abbott Laboratories | Aveir | $286 | 13 payments
|
| Medtronic | Crome Dr Mri Surescan | $87 | 5 payments
|
| Boston Scientific | None | $18 | 1 payment
|
2023: $258
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $97 | 1 payment
|
| Abbott Laboratories | Gallant | $76 | 4 payments
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $38 | 2 payments
|
| Medtronic | Reveal Linq | $24 | 1 payment
|
| Novo Nordisk | Rybelsus | $24 | 1 payment
|
2022: $3,930
| AngioDynamics | Auryon Laser System 100-120 Vac | $3,667 | 1 payment
|
| Abbott Laboratories | 2nd Gen Centrimag Primary Console | $127 | 3 payments
|
| Biotronik | None | $40 | 1 payment
|
| Medtronic | Reveal Linq | $38 | 2 payments
|
| Janssen Biotech | Stelara | $21 | 1 payment
|
| Boston Scientific | General - Therapies | $20 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
2021: $129
| Medtronic | Cobalt | $91 | 5 payments
|
| Edwards Lifesciences | None | $20 | 1 payment
|
| Abbott Laboratories | Confirm Rx | $18 | 1 payment
|
2020: $66
| Medtronic Vascular | Carelink | $55 | 3 payments
|
| Abiomed | Impella | $11 | 1 payment
|
2019: $286
| Medtronic Vascular | Reveal Linq | $109 | 5 payments
|
| Janssen Pharmaceuticals | Xarelto | $93 | 6 payments
|
| Pfizer | Chantix | $26 | 2 payments
|
| Gilead Sciences | Letairis | $24 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $19 | 1 payment
|
| Cardinal Health 200 | Tryton Side Branch Stent | $15 | 1 payment
|
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 78.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 43%That's less than half. | 898 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 69%That's more than half. | 927 |
| Checked for fall riskOlder patients screened for fall risk | 20%That's few of the people this applied to. | 1,492 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 100%That's most of the people this applied to. Worse on this measure. | 400 |
| Medications listed in the chartVisits where the current medication list was documented | 5%That's few of the people this applied to. | 3,572 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 21%That's few of the people this applied to. | 2,499 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
Professional record
- NPI
- 1801898044
- Licence
- CA A96042California A96042: Current · expires 2028-02-29
- Trained
- University of Texas Southwestern Medical School at Dallas, 1997
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 1902828841
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 3621 Forest Glenn Dr, Modesto, CA, 95355
- NPI first listed
- 2005-06-01
- NPI last updated
- 2016-04-20
This is when the NPI record was last certified, not a medical board exam.